Monkeypox: generalities, transmission method and therapeutic approaches
DOI:
https://doi.org/10.33448/rsd-v11i17.38463Keywords:
Monkeypox; Vaccines; Antivirals.Abstract
Clinical and epidemiological studies suggest that human-to-human transmission of monkeypox may occur through direct or indirect contact, through secretions through the respiratory tract or through skin lesions, and through contaminated objects. Therefore, this literature review exposes generalities, forms of transmission and therapeutic approaches related to Monkeypox. A survey was carried out on government websites, scientific articles and journalistic websites about ways of prevention and vaccines against the monkeypox virus. It is known that this zoonosis belongs to the Poxviridae family and spreads with greater intensity in underdeveloped countries, due to the unsanitary conditions of these places. Studies indicate that vaccines produced for smallpox are efficient against Monkeypox virus, especially the third generation ones. The vaccine that obtained a better result in the research was the MVA-BN, since it does not leave lesions in the place where it was applied and does not present a threat to a possible transmission, it was also developed for immunosuppressed individuals, facilitating the mass vaccination of the vaccine. population. Some drugs have also been shown to be effective against Monkeypox, namely: Brincidofovir, Cidofovir and Tecovirimat, with Tecovirimat in evidence for its efficiency and moderate side effects.
References
Butantan Institute. (2022). Varíola dos macacos: sintomas, transmissão, origem e número de casos são atualizados pela OMS. https://butantan.gov.br/noticias/variola-dos-macacos-sintomas-transmissao-origem-e-numero-de-casos-sao-atualizados-pela-oms
Centers for Disease Control and Prevention. (2022). Monkeypox https://www.cdc.gov/poxvirus/monkeypox/clinicians/treatment.html
CNN Brasil. (2022). Como funciona o antiviral tecovirimat contra monkeypox, aprovado pela Anvisa https://www.cnnbrasil.com.br/saude/como-funciona-o-antiviral-tecovirimat-contra-monkeypox-aprovado-pela-anvisa/
Di Giulio, D. B., & Eckburg, P. B. (2004). Human monkeypox: an emerging zoonosis, 10.1016/s1473-3099(03)00856-9
European medicines Agency. (2022). Tecovirimat SIGA (tecovirimat) https://www.ema.europa.eu/en/documents/overview/tecovirimat-siga-epar-medicine-overview_pt.pdf;
G. Sambo, L. (2007). http://files.bvs.br/upload/S/1555-8746/2007/vn4/a135-154-2.pdf
Hospital Proncor. (2022). What is Monkeypox? Know the symptoms and why it affects humans https://www.hospitalproncor.com.br/amp/variola
Hospital Sírio-Libanês. (2019). Information about the drug Cidofovir https://guiafarmaceutico.hsl.org.br/cidofovir
INDICE.eu. (2022). Brincidofovir https://www.indice.eu/pt/medicamentos/DCI/brincidofovir/informacao-geral#:~:text=Brincidofovir%20%C3%A9%20indicado%20para%20o,Unidos%20em%20junho%20de%202021)
Manual MSD (2022). Antiviral Medicines https://www.msdmanuals.com/pt-pt/casa/multimedia/video/medicamentos-antivirais).
Mckeever, A. (2022). How effective is the common smallpox vaccine against monkeypox? https://www.nationalgeographicbrasil.com/ciencia/2022/08/quao-eficiente-e-a-vacina-da-variola-comum-contra-a-variola-dos-macacos
Ministry of Health. (2022). Entenda a origem da varíola dos macacos; transmissão atual ocorre somente entre humanos https://www.gov.br/saude/pt-br/assuntos/noticias/2022/agosto/entenda-a-origem-da-variola-dos-macacos-transmissao-atual-ocorre-somente-entre-humanos
Nalca, A., & Zumbrun, E. E. (2010). ACAM2000™: ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile, https://doi.org/10.2147/DDDT.S3687
National Commission for the Incorporation of Technologies in the Unified Health System. (2022). Tecovirimat for the treatment of monkeypox https://www.gov.br/conitec/pt-br/midias/radar/2022/20220909_alerta_mht_tecoviramat_monkey.pdf
Peduzzi, P. (2022). Entenda o que é a varíola dos macacos. https://agenciabrasil.ebc.com.br/saude/noticia/2022-05/entenda-o-que-e-variola-dos-macacos
Pharmacy diary. (2022). Tecovirimat – treat. ment for Monkeypoxhttps://www.diariofarma.com.br/tecovirimat-tratamento-para-variola-de-macaco/#:~:text=Os%20efeitos%20secund%C3%A1rios%20mais%20frequentes,foi%20autorizado%20em%20circunst%C3%A2ncias%20excecionais
Petersen, B. W., Kabamba, J., McCollum, A. M., Lushima, R. S., Wemakoy, E. O., Tamfum, J. M., Nguete, B., Hughes, C. M., Monroe, B. P., & Reynolds, M. G., (2022). Vaccinating against monkeypox in the Democratic Republic of the Congo, 10.1016/j.antiviral.2018.11.004
Pinheiro, L. (2022). Monkeypox: Here's What We Know About Vaccination https://g1.globo.com/saude/vacina/noticia/2022/07/25/variola-dos-macacos-veja-o-que-se-sabe-sobre-a-vacinacao.ghtml
Rizk, J. G., Lippi, G., Henry, B. M., Forthal, D. N., & Rizk, Y. (2022). Prevention and Treatment of Monkeypox, 10.1007/s40265-022-01742-y
Rocha, L. (2022). Como funciona o antiviral tecovirimat contra varíola dos macacos, que deve chegar ao Brasil. https://www.cnnbrasil.com.br/saude/como-funciona-o-antiviral-tecovirimat-contra-variola-dos-macacos-que-deve-chegar-ao-brasil/
Rocha, L. (2022). Entenda quais são e como funcionam as vacinas contra a varíola. https://www.cnnbrasil.com.br/saude/entenda-quais-sao-e-como-funcionam-as-vacinas-contra-a-variola/
Soheili, M., Nasseri, S., Afraie, M., Khateri S., Moradi Y., Mortazavi, S. M. M., & Gilzad-Kohan, H. (2022). Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments, 10.18433/jpps33138.
Stephens, P. R. S., Oliveira, B. S. C., Ribeiro, F. C., & Carneiro, L. A. D. (2009). Virologia https://www.arca.fiocruz.br/bitstream/handle/icict/13725/Conceitos%20e%20Metodos%20V4_Virologia.pdf;jsessionid=BAB0B48BE8802C687EABF502E31BB348?sequence=2
The United Nations Children's Fund. (2019). Vaccines, questions and answers - guidelines https://www.unicef.org/brazil/vacinas-perguntas-e-respostas
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ana Carolina Bastos do Rêgo; Letícia Almeida Guedes de Lima; Marvin Gonçalves Duarte; Lucas de Jesus Santana do Amaral; Zélia Maria Sarmento de Andrade Lima Fischer de Lyra; Diogo Acioli Filizola Germano; Fernanda de Oliveira Dantas ; Geovanna Esther Pereira Santiago ; Guilherme Marinho Sampaio; Luciano Barreto Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.